The Pharmaceutical Biochemistry Group: Where Pharmaceutical Chemistry Meets Biology and Drug Delivery

Authors

  • Yogeshvar N. Kalia School of Pharmaceutical Sciences University of Geneva 30 Quai Ernest-Ansermet 1211 Geneva 4, Switzerland. Yogi.Kalia@unige.ch
  • Remo Perozzo School of Pharmaceutical Sciences University of Geneva 30 Quai Ernest-Ansermet 1211 Geneva 4, Switzerland. Remo.Perozzo@unige.ch
  • Leonardo Scapozza School of Pharmaceutical Sciences University of Geneva 30 Quai Ernest-Ansermet 1211 Geneva 4, Switzerland. Leonardo.Scapozza@unige.ch

DOI:

https://doi.org/10.2533/chimia.2012.313

Keywords:

Cancer, Drug delivery, Drug discovery and development, Neglected diseases, Pharmaceutical biochemistry and chemistry, Transdermal

Abstract

Successful drug discovery and development of new therapeutics is a long, expensive multidisciplinary process needing innovation and the integration of smart cutting edge science and technology to overcome the challenges in taking a drug from the bench to the bedside. The research activities of the Pharmaceutical Biochemistry group span the drug discovery and development process, providing an interface that brings together pharmaceutical chemistry, biochemistry, structural biology, computational chemistry and biopharmaceutics. Formulation and drug delivery are brought into play at an earlier stage when facing the perennial challenge of transforming a potent molecule in vitro into a therapeutic agent in vivo. Concomitantly, drug delivery results can be understood at a molecular level. This broad range of interdisciplinary research activities and competences enables us to address key challenges in modern drug discovery and development, provides a powerful collaborative platform for other universities and the pharmaceutical industry and an excellent training platform for pharmacists and pharmaceutical scientists who will later be involved in drug discovery and development.

Downloads

Published

2012-05-30

Issue

Section

Scientific Articles

How to Cite